[Serum smooth muscle antibodies with anti-actin specificity appeared during treatment with interferon alpha].
Grimbert
S
S
Mohib
S
S
Johannet
C
C
Trinchet
J C
JC
Beaugrand
M
M
D000199:Actins / Q000276:immunology*; D000906:Antibodies / Q000302:isolation & purification*; D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006526:Hepatitis C / Q000628:therapy*; D006801:Humans; D007154:Immune System Diseases / Q000139:chemically induced; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009130:Muscle, Smooth / Q000276:immunology*
D000199:Actins; D000906:Antibodies; D000998:Antiviral Agents; D016898:Interferon-alpha
Anticorps sériques anti-muscle lisse de spécificité anti-actine apparus au décours d'un traitement par interféron alpha.